Cernostics Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 15

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $80.7M

Cernostics General Information

Description

Developer of spatial biology and AI-driven image analytics device intended to provide valuable insight to pharma clients on the pathophysiology of the disease, biomarker discovery and validation, and clinical trial support. The company's high complexity clinical reference laboratory equipment specializes in the high-dimensional analysis of tissue biopsies, providing valuable information to clinicians not available through other means, offering clients novel biological insights, better patient outcomes, and lower overall cost of care.

Contact Information

Formerly Known As
Cernostics Pathology, Cernostics Pathology, Inc.
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 235 William Pitt Way
  • Building B1
  • Pittsburgh, PA 15238
  • United States
+1 (412)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 235 William Pitt Way
  • Building B1
  • Pittsburgh, PA 15238
  • United States
+1 (412)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cernostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 03-Dec-2021 $80.7M Completed Generating Revenue
11. Later Stage VC (Series B1) 13-Aug-2021 Completed Generating Revenue
10. Later Stage VC (Series A1) 21-Mar-2018 Completed Generating Revenue
9. Later Stage VC (Series BB) 31-Aug-2016 Completed Generating Revenue
8. Grant 01-Jul-2015 Completed Generating Revenue
7. Later Stage VC (Series AA) 08-Jun-2015 Completed Generating Revenue
6. Later Stage VC (Series B) 31-Jul-2013 Completed Generating Revenue
5. Grant 01-Jun-2012 Completed Startup
4. Grant 01-Oct-2010 $244K $3.06M Completed Startup
3. Early Stage VC (Series A) 01-May-2010 $2.71M $3.06M Completed Startup
To view Cernostics’s complete valuation and funding history, request access »

Cernostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B1
Series A1
To view Cernostics’s complete cap table history, request access »

Cernostics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of spatial biology and AI-driven image analytics device intended to provide valuable insight to pharma clients
Decision/Risk Analysis
Pittsburgh, PA
15 As of 2021

Waltham, MA
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cernostics Competitors (21)

One of Cernostics’s 21 competitors is BostonGene, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BostonGene Venture Capital-Backed Waltham, MA
Tempus AI Formerly VC-backed Chicago, IL
Strata Oncology Venture Capital-Backed Ann Arbor, MI
Genomic Expression Venture Capital-Backed Beverly, MA
Metamark Genetics Formerly VC-backed Waltham, MA
You’re viewing 5 of 21 competitors. Get the full list »

Cernostics Patents

Cernostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4152001-B1 Methods of classifying barrett's esophagus Active 25-Nov-2015
ES-3056977-T3 Methods of classifying barrett's esophagus Active 25-Nov-2015
EP-3786640-B1 Methods of detecting malignant transformation of barrett's esophagus Active 25-Nov-2015
AU-2016359685-A1 Methods of predicting progression of barrett's esophagus Active 25-Nov-2015
AU-2016359685-B2 Methods of predicting progression of barrett's esophagus Active 25-Nov-2015 G01N33/5758
To view Cernostics’s complete patent history, request access »

Cernostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cernostics Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ben Franklin Technology Partners of Northeastern Pennsylvania Venture Capital Minority
Commonwealth Universal Research Enhancement Program Government
Geisinger Health System Corporation Minority
Illumina Ventures Venture Capital Minority
National Cancer Institute Government
You’re viewing 5 of 10 investors. Get the full list »

Cernostics FAQs

  • When was Cernostics founded?

    Cernostics was founded in 2008.

  • Where is Cernostics headquartered?

    Cernostics is headquartered in Pittsburgh, PA.

  • What is the size of Cernostics?

    Cernostics has 15 total employees.

  • What industry is Cernostics in?

    Cernostics’s primary industry is Decision/Risk Analysis.

  • Is Cernostics a private or public company?

    Cernostics is a Private company.

  • What is the current valuation of Cernostics?

    The current valuation of Cernostics is .

  • What is Cernostics’s current revenue?

    The current revenue for Cernostics is .

  • How much funding has Cernostics raised over time?

    Cernostics has raised $16.2M.

  • Who are Cernostics’s investors?

    Ben Franklin Technology Partners of Northeastern Pennsylvania, Commonwealth Universal Research Enhancement Program, Geisinger Health System, Illumina Ventures, and National Cancer Institute are 5 of 10 investors who have invested in Cernostics.

  • Who are Cernostics’s competitors?

    BostonGene, Tempus AI, Strata Oncology, Genomic Expression, and Metamark Genetics are some of the 21 competitors of Cernostics.

  • When was Cernostics acquired?

    Cernostics was acquired on 03-Dec-2021.

  • Who acquired Cernostics?

    Cernostics was acquired by Castle Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process